RecruitingNCT05548530

Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage

Analysis of Related Factors of Hematoma Morphology in Patients With Cerebral Hemorrhage and Prognosis Analysis of Different Regimens for Cerebral Hemorrhage


Sponsor

The Affiliated Hospital Of Guizhou Medical University

Enrollment

1,000 participants

Start Date

Jan 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

To analyze the influence of early hematoma morphology on hematoma expansion, optimize the treatment plan for cerebral hemorrhage, and guide the treatment of patients with cerebral hemorrhage in combination with clinical practice.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

  • Age 18-80 years old;
  • Intracerebral hemorrhage was diagnosed by head CT examination;

Exclusion Criteria7

  • Multiple intracranial hemorrhage;
  • Intracranial hemorrhage caused by intracranial tumor, aneurysm, trauma, infarction or other lesions;
  • Coagulation disorders or a history of taking anticoagulants;
  • Infectious meningitis, systemic infection;
  • History of severe stroke, heart, kidney, liver and lung dysfunction in the past;
  • Severe brain herniation (mydriasis, respiratory and circulatory failure);
  • Incomplete or missing basic data or follow-up information in the hospital.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREStereotactic intracranial hematoma puncture

Check the CT scan of the patient's brain, find out the largest hematoma level of the patient, measure the coordinates of the puncture center, locate and mark the skull surface according to the coordinates obtained from the measurement, select the puncture point under the stereotaxic instrument, and mainly avoid important blood vessels , nerves and functional areas. Use an electric drill to drill the puncture needle into the center of the hematoma, and slowly aspirate the hematoma from the side hole until the suction stops when there is resistance. The residual hematoma in CT and the location of the drainage tube were determined, and the position of the puncture needle was adjusted for the situation of brain CT. After the operation, according to the re-examination of cranial CT, urokinase was injected into the hematoma cavity through the drainage tube to dissolve the residual hematoma, and the operation process strictly followed aseptic operation.

PROCEDUREdecompressive craniectomy

Prior to the procedure, all patients obtained endotracheal intubation under general anesthesia following the informed consent provided by their family members. Upon identifying the hematoma's location through CT imaging, the surgeon made a linear or horseshoe-shaped incision on the scalp and subsequently opened the dura mater after creating a bone flap. The hematoma was punctured using a brain needle, allowing for effective decompression. The cerebral cortex was incised along the cerebral gyri, facilitating the separation of brain tissue to eliminate residual hematoma. Once hemostasis was ensured within the operative area, a silicone drainage tube was inserted, and the cranial bone flap was restored to its original position. In cases of severe brain edema or cerebral herniation, bone flap decompression was performed.

PROCEDURENeuroendoscopic

The patient's preoperative CT and MR imaging data were fused with a neuronavigation system to avoid important functional areas and select the closest point of the hematoma to the cortex as the location point. Routine craniotomy was performed with a 2\*3 cm bone window, the puncture direction was repositioned by neuronavigation, the sheath was placed at the center of the hematoma, the core was removed, the endoscope was gradually aspirated, and the bleeding was stopped with electrocoagulation if there was considerable active bleeding. A drainage tube was placed, the bone flap was reset after surgery, and the scalp was sutured.


Locations(1)

Guizhou Medical University Affiliated Hospital

Guiyang, Guizhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05548530


Related Trials